Novozymes Statistics
Total Valuation
Novozymes has a market cap or net worth of 28.33 billion. The enterprise value is 31.70 billion.
| Market Cap | 28.33B |
| Enterprise Value | 31.70B |
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | Sep 2, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -30.69% |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 26.38% |
| Float | 346.37M |
Valuation Ratios
The trailing PE ratio is 44.15 and the forward PE ratio is 24.69.
| PE Ratio | 44.15 |
| Forward PE | 24.69 |
| PS Ratio | 5.83 |
| PB Ratio | 2.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 30.87 |
| P/OCF Ratio | 21.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.54, with an EV/FCF ratio of 34.53.
| EV / Earnings | 49.39 |
| EV / Sales | 6.43 |
| EV / EBITDA | 15.54 |
| EV / EBIT | 23.63 |
| EV / FCF | 34.53 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.61 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | 3.97 |
| Interest Coverage | 16.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.49% |
| Return on Capital Employed (ROCE) | 7.50% |
| Weighted Average Cost of Capital (WACC) | 7.75% |
| Revenue Per Employee | 459,295 |
| Profits Per Employee | 60,649 |
| Employee Count | 10,582 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Novozymes has paid 177.75 million in taxes.
| Income Tax | 177.75M |
| Effective Tax Rate | 21.69% |
Stock Price Statistics
The stock price has increased by +8.89% in the last 52 weeks. The beta is 0.78, so Novozymes's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +8.89% |
| 50-Day Moving Average | 62.90 |
| 200-Day Moving Average | 65.22 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 46,755 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novozymes had revenue of 4.86 billion and earned 641.79 million in profits. Earnings per share was 2.24.
| Revenue | 4.86B |
| Gross Profit | 2.85B |
| Operating Income | 1.33B |
| Pretax Income | 819.55M |
| Net Income | 641.79M |
| EBITDA | 2.02B |
| EBIT | 1.33B |
| Earnings Per Share (EPS) | 2.24 |
Balance Sheet
The company has 330.05 million in cash and 3.65 billion in debt, with a net cash position of -3.32 billion.
| Cash & Cash Equivalents | 330.05M |
| Total Debt | 3.65B |
| Net Cash | -3.32B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.61B |
| Book Value Per Share | 26.97 |
| Working Capital | 873.17M |
Cash Flow
In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -399.04 million, giving a free cash flow of 917.99 million.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -399.04M |
| Free Cash Flow | 917.99M |
| FCF Per Share | n/a |
Margins
Gross margin is 58.55%, with operating and profit margins of 27.32% and 13.20%.
| Gross Margin | 58.55% |
| Operating Margin | 27.32% |
| Pretax Margin | 16.86% |
| Profit Margin | 13.20% |
| EBITDA Margin | 41.48% |
| EBIT Margin | 27.32% |
| FCF Margin | 18.89% |
Dividends & Yields
This stock pays an annual dividend of 0.56, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | 0.56 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | 60.84% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 73.62% |
| Buyback Yield | 30.69% |
| Shareholder Yield | 31.61% |
| Earnings Yield | 2.27% |
| FCF Yield | 3.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.
| Last Split Date | Dec 9, 2011 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Novozymes has an Altman Z-Score of 4.34 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.34 |
| Piotroski F-Score | 4 |